Unilever Extends Collaboration with Transinsight in the Field of Semantic Searching

GoPubMedUnilever, one of the world's largest consumer products companies, will continue working with Transinsight towards a tailored solution from GoPubMed that meets Unilever Research's diverse scientific data mining requirements. Today's searching is mostly split between Internet and intranet searches. The integration of both worlds under one semantic umbrella is the goal of a continuing collaboration between Unilever and Transinsight, provider of solutions for knowledge-based semantic search technology. Unilever has chosen Transinsight for corporate semantic searching.

"GoPubMed is a fantastic semantic search engine that fits the needs of most users searching biomedical literature from the MEDLINE database. But we believe that the system can lead to a lot more insight and time saving if users get the chance to customise the underlying knowledge base so that the system can be used to search the Internet as well as our in-house data", says Wendy Filsell, a senior informatician in the Unilever Information Group. "For two years, GoPubMed has been in use at Unilever with great success in the fields of nutrition and metabolism, among others. We believe continuing to walk the road paved with semantic technologies from Transinsight will bring us better insights much faster."

Transinsight's search technology is made for the next generation of semantic searching. Its power lies in its ability to intelligently match huge amounts of textual material to very big classification networks like the Gene Ontology, MeSH or customer-tailored ontologies according to company needs. "Where traditional techniques take months we need only a few days," says Dr. Liliana Barrio-Alvers, CTO of Transinsight. She continues, "We are proud to have developed a technology that is unparalleled worldwide when it comes to meaningful semantic searches. Transinsight's core algorithms allow our customers to speed up their tedious daily work significantly because the search results are sorted in a smart way."

The free search platform www.GoPubMed.com will benefit from the collaboration between Unilever and Transinsight since both parties have agreed to include many of the jointly developed features in the open search platform. "We know that GoPubMed helps the biomedical community when it comes to getting answers for more and more complex questions. The Wikipedia-like collaboration applied to the knowledge-network makes the search more intelligent every day since the users improve it for the benefit of themselves and others", says Dr. Michael R. Alvers, CEO of Transinsight.

Related news articles:

About Unilever
Unilever's mission is to add vitality to life. We meet everyday needs for nutrition, hygiene and personal care with brands that help people feel good, look good and get more out of life. Unilever is one of the world's leading suppliers of fast moving consumer goods with strong local roots in more than 100 countries across the globe. Its portfolio includes some of the world's best known and most loved brands including twelve €1 billion brands and global leadership in many categories in which the company operates. The portfolio features brand icons such as Flora/Becel, Bertolli, Dove, Lux, Pond's, Lynx, Sunsilk, Omo, Cif and Domestos. Unilever has around 179,000 employees in nearly 100 countries and generated annual sales of €40 billion in 2006. For more information about Unilever and its brands, visit www.unilever.com.

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...